share_log

B of A Securities Reinstates Underperform on Amgen, Announces $256 Price Target

Benzinga ·  Dec 10, 2024 20:29  · Ratings

B of A Securities analyst Tim Anderson reinstates Amgen (NASDAQ:AMGN) with a Underperform and announces $256 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment